Autolus Therapeutics plc American Depositary Share (AUTL) is a publicly traded Healthcare sector company. As of September 13, 2026, AUTL trades at $1.91 with a market cap of $500.39M and a P/E ratio of -1.80. AUTL moved -4.08% today. Year to date, AUTL is -5.53%; over the trailing twelve months it is +31.47%. Its 52-week range spans $1.11 to $2.70. Analyst consensus is strong buy with an average price target of $8.16. Rallies surfaces AUTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for AUTL, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.91 |
| Market Cap | $500.39M |
| P/E Ratio | -1.80 |
| EPS | $-1.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.70 |
| 52-Week Low | $1.11 |
| Volume | 1.66M |
| Avg Volume | 0 |
| Revenue (TTM) | $117.39M |
| Net Income | $-280.16M |
| Gross Margin | 15.66% |
6 analysts cover AUTL: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.16.